Correlation between soluble FLT1 and clinical features of patients with Hereditary Hemorrhagic Telangiectasia

Completed

• Conditions: 10083624; Hereditary Hemorrhagic Telangiectasia; Rendu-Osler-Weber syndrome; 10047075

• Registration Number: NL-OMON45691
• Lead Sponsor: Sint Antonius Ziekenhuis

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 15 April 2024

Recruitment & Eligibility

• Status: Completed
• Sex: Not specified
• Target Recruitment: 30

Inclusion Criteria

Patients with (I) hereditary hemorrhagic telangiectasia type 2 (ACVRL1 mutation) who have been screened previously by the st antonius hospital, HHT centre of exellence, (II) 18 years or older and (III) mentally competent.

Exclusion Criteria

None

Study & Design

• Study Type: Observational invasive
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
<p>Level of sFLT1 in correlation to symptom severity.</p><br>

Secondary Outcome Measures

Name	Time	Method
<p>geen</p><br>